Cost-effectiveness of screening for open angle glaucoma in developed countries
2011

Cost-effectiveness of Glaucoma Screening

publication Evidence: low

Author Information

Author(s): Anja Tuulonen

Primary Institution: University of Oulu and Tampere University Hospital, Finland

Hypothesis

Is systematic population screening for glaucoma cost-effective in developed countries?

Conclusion

There is currently insufficient evidence to determine if systematic population screening for glaucoma is cost-effective in developed countries.

Supporting Evidence

  • Glaucoma is the second most common cause of visual disability in the elderly in developed countries.
  • More than half of glaucoma patients are undiagnosed.
  • Half of the patients treated for glaucoma do not have the disease.

Takeaway

This study looks at whether screening for glaucoma is worth the money in developed countries, and it finds that we don't have enough information to say yes or no.

Methodology

The article reviews existing literature on the cost-effectiveness of glaucoma screening and discusses the need for future research.

Potential Biases

Potential biases exist due to the reliance on limited and possibly non-representative studies.

Limitations

The evidence on the cost-effectiveness of screening is limited and varies by population and definitions of glaucoma.

Participant Demographics

The study discusses glaucoma in the context of developed countries, particularly focusing on elderly populations.

Digital Object Identifier (DOI)

10.4103/0301-4738.73684

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication